Erin Shannon

机构：Amgen (United States), Amgen (United Kingdom) · ORCID：0000-0003-2241-264X

发表论文 9 篇 · 总被引 125 次 · h-index 4

代表论文

Ischemic Event Rates in Very-High-Risk Adults (2019 · Journal of the American College of Cardiology · 被引 55)
Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease (2021 · Journal of the American College of Cardiology · 被引 52)
Evaluating a Simple Approach to Identify Adults Meeting the 2018 AHA/ACC Cholesterol Guideline Definition of Very High Risk for Atherosclerotic Cardiovascular Disease (2021 · Cardiovascular Drugs and Therapy · 被引 11)
Low-Density Lipoprotein Cholesterol Testing Following Myocardial Infarction Hospitalization Among Medicare Beneficiaries (2023 · JACC Advances · 被引 5)
LIPID LOWERING THERAPY USE IN HIGH RISK ASCVD PATIENTS WITHOUT PRIOR MI OR STROKE - PRELIMINARY DATA FROM VESALIUS-REAL, US (2025 · Journal of the American College of Cardiology · 被引 1)
Abstract 4139074: Clinical characteristics and treatment of high-risk cardiovascular patients without prior myocardial infarction or stroke: VESALIUS-REAL - results from US (2024 · Circulation · 被引 1)